Perceptions about screening for prostate cancer using genetic lifetime risk assessment: a qualitative study
Abstract Background Most health authorities do not recommend screening for prostate cancer with PSA tests in asymptomatic patients who are not at increased risk. However, opportunistic screening for prostate cancer is still wanted by many patients and it is widely used in primary care clinics, with...
Main Authors: | Pia Kirkegaard, Adrian Edwards, Trine Laura Overgaard Nielsen, Torben Falck Ørntoft, Karina Dalsgaard Sørensen, Michael Borre, Flemming Bro |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-02-01
|
Series: | BMC Family Practice |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12875-018-0717-6 |
Similar Items
-
Dysbiotic microbes and how to find them: a review of microbiome profiling in prostate cancer
by: Paul Vinu Salachan, et al.
Published: (2022-01-01) -
Clinical analysis of EV‐Fingerprint to predict grade group 3 and above prostate cancer and avoid prostate biopsy
by: Adrian Fairey, et al.
Published: (2023-08-01) -
The role of lung cancer risk and comorbidity in lung cancer screening use
by: Ilana B. Richman, et al.
Published: (2022-12-01) -
Patient and Clinician Characteristics That Predict Breast Cancer Screening Behavior in 40–49-Year-Old Women
by: Sarina Schrager, et al.
Published: (2021-10-01) -
A new approach to prostate cancer screening
by: Filella Xavier, et al.
Published: (2023-08-01)